Current filters:

Sumatriptan Succinate

1 to 9 of 114 results

India’s Dr Reddy’s posts unexpected 3rd-qtr loss, revises forecasts


India’s second largest drugmaker Dr Reddy’s Laboratories surprised investors yesterday, by…

Asia-PacificFinancialGenericsGlaxoSmithKlineGSKImitrexPharmaceuticalSumatriptan Succinate

Big upside for Ranbaxy as it launches generic version of Glaxos herpes drug Valtrex


Ranbaxy Laboratories, Indias top drugmaker in terms of sales, has just launched a copycat version of…

Anti-viralsAsia-PacificGenericsImitrexRanbaxy LaboratoriesSumatriptan SuccinateValacyclovir HydrochlorideValtrex

US FDA approves Ranbaxy’s generic sumatriptan


The US subsidiary of Indian drugmaker Ranbaxy has received final approval from the U. Food and Drug Administration…

GenericsGlaxoSmithKlineGSKImitrexNorth AmericaSumatriptan Succinate

Dr Reddy's falls to loss on goodwill adjustment


India-based generics major Dr Reddy's Laboratories has fallen into loss for the 12 months to March 31,…

Dr Reddy's LaboratoriesGlaxoSmithKlineGSKImitrexSumatriptan Succinate

MAP shares surge 192% as migraine drug Levadex meets late-stage study endpoints


MAP Pharmaceuticals' orally-inhaled migraine drug Levadex (dihydroergotamine) met all four primary endpoints…

AstraZenecaD. H. E. 45DihydroergotamineGlaxoSmithKlineGSKImitrexNystatinOralSumatriptan SuccinateZolmitriptanZomig

1 to 9 of 114 results

Back to top